Schedule 13G ownership disclosure

BRAINSTORM CELL THERAPEUTICS INC

Security class unavailable · CUSIP: 10501E102

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
696,165
Percent of class
3.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000107
Form type
SC 13G/A
Filer
BRAINSTORM CELL THERAPEUTICS INC.
CIK
CIK 1137883
Filed
Jan 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub